PHILADELPHIA, June 21 /PRNewswire/ -- Premier Research was short-listed for the Breakthrough of the Year at the upcoming London Stock Exchange Mediscience Awards 2007.
Since the launch of the techMARK Mediscience market in November 2001 -- the first international market specifically for healthcare companies -- the London Stock Exchange Mediscience Awards have been established as the annual event for all quoted Mediscience companies, recognising excellence within the quoted life-sciences sector.
The Breakthrough of the Year award will go to the company which has achieved the most significant breakthrough during the period April 2006 to March 2007. This breakthrough could be a new discovery, departure or breakthrough in technology, a significant positive change in its financial position, a significant commercial or corporate transaction or other breakthrough which has added significantly to the company’s or organisation’s fortunes.
This year’s awards ceremony will be held on Thursday 21 June 2007 at the Hotel Inter-Continental, London.
Dr. Simon Yaxley, Chief Executive Officer of Premier Research, stated, “We are honoured and grateful to be recognised by such a prominent organisation for this prestigious award. It is a credit to the hard work of all our employees and business partners. As a leading life sciences service company, we strive to provide our stakeholders -- whether clients, employees, or shareholders -- with exceptional service, quality, and value. We look forward to continued growth and success.”
Premier Research was nominated in 2006 for Company of the Year and Chief Executive of the Year and in 2005 for Best Newcomer.
About Premier Research
Premier Research is a leading solutions-driven CRO leveraging our commitment to therapeutic focus and scientific expertise to deliver services of the highest quality for Phase I-IV clinical trials. Premier Research is a leader in clinical research for Analgesia, CNS, Infectious Disease and Oncology and has a wealth of experience in pediatric research.
Premier Research has 28 offices and operates in more than 30 countries across Europe and North America. Premier Research employs more than 750 clinical professionals dedicated first and foremost to fulfilling each client’s requirements in a timely, accurate and cost-effective manner. This includes a strong international network of monitors and project management professionals combined with regulatory, data management, statistical, scientific and medical experts, and staff at our well-established network of dedicated clinical sites.
Premier Research
CONTACT: Dr. Simon Yaxley, Chief Executive Officer of Premier ResearchGroup plc, +44-0-1344-458-311
